Impact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field Trial.


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
04 2020
Historique:
received: 20 05 2019
accepted: 07 11 2019
pubmed: 13 11 2019
medline: 13 11 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

Hearing, vision, and cognitive impairment commonly co-occur in older adults. Improving sensory function may positively impact outcomes in people with dementia (PwD). We developed a "sensory intervention" (SI) to support hearing and vision in PwD. Here, we report the findings of an international open-label field trial, and nested case series, to explore the impact of the SI on dementia-related outcomes. This was a home-based trial conducted in France, England, and Cyprus. Participants were people with mild-to-moderate dementia and hearing and/or vision impairment (n = 19) and their study partners (unpaid carers; n = 19). The "basic" SI included a hearing and vision assessment and provision of glasses and/or hearing aids. A subsample received the "extended" SI with additional weekly visits from a sensory support therapist (SST). Exploratory analyses of dementia-related, health utility and resource utilisation outcomes were performed. Quality of life (QoL) and sensory functional ability improved. Change in QoL exceeded the threshold for a minimum clinically important difference. There was a modest improvement (in absolute terms) post intervention in behavioural disturbance, self-efficacy, and relationship satisfaction. Study partner time assisting instrumental activities of daily living (iADL) and supervision decreased by about 22 and 38 hours per month, respectively, although time for personal ADL support increased. Qualitative data supported effectiveness of the intervention: PwD were more socially engaged, less isolated, less dependent on study partners, and had improved functional ability and communication. These findings support the need for a definitive randomised controlled trial (RCT) to evaluate the effectiveness of the intervention.

Identifiants

pubmed: 31713262
doi: 10.1002/gps.5231
pmc: PMC7079053
doi:

Banques de données

ISRCTN
['ISRCTN35019114']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

348-357

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

Alzheimers Dement. 2013 Jul;9(4):429-435.e17
pubmed: 23142433
Br J Ophthalmol. 2007 Oct;91(10):1279-81
pubmed: 17360732
Int J Geriatr Psychiatry. 2019 May;34(5):709-721
pubmed: 30724405
Health Econ. 2018 Jan;27(1):7-22
pubmed: 28833869
Ear Hear. 1982 May-Jun;3(3):128-34
pubmed: 7095321
Int J Geriatr Psychiatry. 2020 Apr;35(4):348-357
pubmed: 31713262
Health Technol Assess. 2005 Mar;9(10):1-93, iii-iv
pubmed: 15774233
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Int Psychogeriatr. 2019 Feb;31(2):203-221
pubmed: 30244688
Aging Ment Health. 2017 Sep;21(9):961-967
pubmed: 27215277
Psychol Med. 1997 May;27(3):647-57
pubmed: 9153685
Optom Vis Sci. 2007 Aug;84(8):705-9
pubmed: 17700334
Health Technol Assess. 2013 Feb;17(5):v-xv, 1-140
pubmed: 23402232
J Am Acad Audiol. 2010 Nov-Dec;21(10):642-53
pubmed: 21376005
J Speech Lang Hear Res. 2013 Oct;56(5):1364-72
pubmed: 23838985
J Am Acad Audiol. 2018 Mar;29(3):233-242
pubmed: 29488873
BMJ Open. 2017 Nov 28;7(11):e018744
pubmed: 29187416
Pilot Feasibility Stud. 2017 Sep 11;3:38
pubmed: 28912959
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Am Geriatr Soc. 2019 Jul;67(7):1472-1477
pubmed: 31034588
Qual Life Res. 2016 Dec;25(12):3107-3118
pubmed: 27318488
PLoS Med. 2017 Mar 28;14(3):e1002269
pubmed: 28350796
Psychosom Med. 2002 Mar-Apr;64(2):258-66
pubmed: 11914441
Age Ageing. 1996 Mar;25(2):113-20
pubmed: 8670538
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Stroke. 2003 Aug;34(8):1907-12
pubmed: 12855825
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Nurse Res. 1997 May 1;4(3):5-16
pubmed: 27285770
Psychopharmacol Bull. 1988;24(4):709-11
pubmed: 3249773
Trials. 2013 May 27;14:152
pubmed: 23710796
Med Care. 2004 Sep;42(9):851-9
pubmed: 15319610
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
N Engl J Med. 2012 Mar 8;366(10):893-903
pubmed: 22397651
Trials. 2019 Jan 25;20(1):80
pubmed: 30683150

Auteurs

Iracema Leroi (I)

Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.
Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.

Zoe Simkin (Z)

Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.

Emma Hooper (E)

Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.

Lucas Wolski (L)

Institute of Applied Research, Development and Further Education, Catholic University of Applied Sciences Freiburg, Freiburg, Germany.

Harvey Abrams (H)

Department of Communication Sciences and Disorders, University of South Florida, Tampa, FL.

Christopher J Armitage (CJ)

Division of Psychology and Mental Health, University of Manchester, Manchester, UK.

Elizabeth Camacho (E)

Manchester Centre for Health Economics, University of Manchester, Manchester, UK.

Anna Pavlina Charalambous (AP)

Department of Health Sciences, European University Cyprus, Nicosia, Cyprus.

Fideline Collin (F)

INSERM, EUCLID/F-CRIN Clinical Trials Platform, University of Bordeaux, Talence, Aquitaine, France.

Fofi Constantinidou (F)

Centre for Applied Neurosciences, University of Cyprus, Nicosia, Cyprus.

Piers Dawes (P)

Manchester Centre for Audiology and Deafness, University of Manchester, Manchester, UK.

Rachel Elliott (R)

Manchester Centre for Health Economics, University of Manchester, Manchester, UK.

Sue Falkingham (S)

Department of Audiology, Starkey Hearing Technologies, Stockport, UK.

Eric Frison (E)

INSERM, EUCLID/F-CRIN Clinical Trials Platform, University of Bordeaux, Talence, Aquitaine, France.

Mark Hann (M)

Centre for Biostatistics, University of Manchester, Manchester, UK.

Catherine Helmer (C)

INSERM, Bordeaux Population Health Research Center, Team LEHA, University of Bordeaux, Talence, Aquitaine, France.

Ines Himmelsbach (I)

Institute of Applied Research, Development and Further Education, Catholic University of Applied Sciences Freiburg, Freiburg, Germany.

Hannah Hussain (H)

Manchester Centre for Health Economics, University of Manchester, Manchester, UK.

Sarah Marié (S)

Research and Development, Essilor International, Paris, France.

Susana Montecelo (S)

Research and Development, Essilor International, Paris, France.

Chryssoula Thodi (C)

Department of Health Sciences, European University Cyprus, Nicosia, Cyprus.

Wai Kent Yeung (WK)

Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH